2 Minutes with Joey - CRSP Stock News

Two minutes with Joey on CRISPR Therapeutics (CRSP) - a quick daily recap of what the stock did today and why, in plain English. Information and entertainment only, not financial advice.

2 Minutes with Joey - CRSP Stock News is a general podcast hosted by Unknown Host, with 0 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Unknown Host hosts 2 Minutes with Joey - CRSP Stock News, a general show with 0 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  2 Minutes with Joey - CRSP Stock News

  CRSP Today - Jul 21: Shares Sold, Steady Day

  Jul 21, 20262 minS0

  Hey there! It’s Joey here, your friendly longtime investor, breaking down the day for CRISPR Therapeutics, or CRSP for short. Today was a pretty solid green day, with the stock up about 3.3%. Not too shabby, right?<br /><br />So, what went down? CRISPR shares were on the rise today, which is nice to see. There wasn’t a huge spike or anything wild, but it’s always great when a stock is moving in the right direction. It seems like people were feeling a bit more optimistic today, maybe because the gene-editing pipeline is looking strong. That’s always a good s...

  ListenShow Notes
• 

  2 Minutes with Joey - CRSP Stock News

  CRSP Today - Jul 19: EPS Concerns Hit Hard

  Jul 19, 20261 minS0

  Hey there! It’s Joey, your friendly neighborhood investor, here to break down what went down with CRISPR Therapeutics today. Spoiler alert: it was a red day. The stock dipped about 1.6%. <br /><br />So, here’s the scoop. CRSP started off strong but ended up getting smoked. The stock hit a bit of a wall after some earnings chatter. People were really worried about how the company’s earnings per share and revenue numbers just didn’t align with the valuation. That divergence had folks hitting the sell button fast. <br /><br />Why the panic? Well, it looks like there's some ser...

  ListenShow Notes
• 

  2 Minutes with Joey - CRSP Stock News

  CRSP Today - Jul 18: CRISPR Takes a Hit

  Jul 18, 20261 minS0

  Hey there! It’s Joey here, your go-to guy for stock chat and a longtime investor. Today, we're talking about CRISPR Therapeutics, and it was a red day for them. The stock dropped about 1.6%. Ouch!<br /><br />So, what happened? Well, CRISPR got smoked today. There was a lot of chatter about their earnings and revenue expectations not lining up with what people thought the stock was worth. Basically, folks were worried that the company might be overvalued. That’s a tough pill to swallow, especially in this market.<br /><br />Now, why did it drop like that? Some insiders sold...

  ListenShow Notes
• 

  2 Minutes with Joey - CRSP Stock News

  CRSP Today - Jul 17: Six-Day Slide Continues

  Jul 17, 20261 minS0

  Hey there! I’m Joey, your friendly neighborhood investor, here to break down what went down with CRISPR Therapeutics today. So, CRSP had a bit of a rough ride, closing down about half a percent. Yeah, it’s been a tough week.<br /><br />Now, here’s the scoop. CRISPR has been sliding for six straight days. That’s right, six! People are starting to wonder if it’s finally hit a cheap price, but honestly, it still feels like a slow bleed. Volume was way below average today, which means not a lot of folks were trading it. It’s like every...

  ListenShow Notes
• 

  2 Minutes with Joey - CRSP Stock News

  CRSP Today - Jul 16: Six Red Days in a Row

  Jul 16, 20262 minS0

  Hey there! It’s Joey here, your go-to guy for breaking down the stock scene. I’ve been in the investing game for years, and today we’re checking out CRISPR Therapeutics, or CRSP. Not a great day for them — the stock got smoked, down over 5%. Ouch.<br /><br />So, what happened? It’s been a rough stretch lately, and today marked six straight red days for CRSP. That’s a total drop of about 18% over this little losing streak. A lot of folks are feeling the pressure and hitting that sell button fast. Volume was pretty low today too, which usuall...

  ListenShow Notes

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.